Cardiovascular risk

Assessing cardiovascular risk

Optimal cardiovascular risk assessment allows doctors to adjust treatment in high-risk patients in an early stage.

Cardiovascular risk in diabetes

Diabetes is associated with numerous long-term vascular complications:
  • Cardiovascular complications – these include peripheral vascular disease and stroke. People with diabetes are two to four times more likely to develop cardiovascular disease than people without diabetes. Furthermore cardiovascular disease is the leading cause of mortality for people with diabetes.
  • Diabetic nephropathy – this condition leads to a deterioration in the ability of the kidneys to properly filter circulating blood due to damage caused to blood vessels from hyperglycemia. Eventually, the condition can progress to end-stage renal disease. However, most patients do not progress to end-stage renal disease as the risk of death from heart disease is more than that from kidney failure.
  • Diabetic retinopathy – broad ophthalmologic problems resulting from hyperglycemia, occurring well after the initial diagnosis of the diabetic condition. Different types of diabetic retinopathy are common such as, proliferative diabetic retinopathy, nonproliferative diabetic retinopathy, and diabetic macular edema (fluid and protein deposition).
  • Diabetic neuropathy – nerve injury may result, temporarily or permanently, due to decreased blood flow and hyperglycemia. Types of neuropathy include autonomic neuropathy, with changes to digestive function and possibly cardiac function and blood pressure; peripheral neuropathy with either pain or loss of feeling or feeling vibrations in the extremities; focal neuropathy, with sudden muscle weakness or pain from a single nerve or group of nerves; and proximal neuropathy, with pain in the thighs and hips.

The AGE Reader is a great tool to identify patients with an increased risk of developing diabetic complications.

Recommended reading: AGE Reader reflects vascular damage in diabetes patients

Read more about cardiovascular risk in renal disease.

More Information
Request informations

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.
Read more »
About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.a